US Patent 7521048 TRAIL receptor-2 polypeptides and antibodies
Patent 7521048 was granted and assigned to Amgen on April, 2009 by the United States Patent and Trademark Office.
All edits
Polypeptides are provided. Antibodies or antigen binding domains are provided which bind such polypeptides. Also provided are methods of obtaining an antibody that binds tumor necrosis factor (TNF)-related apoptosis-inducing ligand (“TRAIL”) Receptor-2 (TR-2) comprising administering at least one of such polypeptides to an animal and obtaining an antibody that binds TR-2 from the animal. Antibodies reactive with TR-2 are provided. Also provided are cells producing antibodies reactive with TR-2, pharmaceutical compositions comprising antibodies reactive with TR-2, methods using antibodies reactive with TR-2, and kits comprising antibodies reactive with TR-2. Also provided are methods of decreasing or preventing binding of an antibody to TR-2 by administering such a polypeptide.
US Patent 07521048 TRAIL receptor-2 polypeptides and antibodies US Patent 7521048 TRAIL receptor-2 polypeptides and antibodies
US Patent 07521048 TRAIL receptor-2 polypeptides and antibodies
Find more entities like US Patent 7521048 TRAIL receptor-2 polypeptides and antibodies
